The FTD Biomarkers Initiative from The Association for Frontotemporal Degeneration (AFTD) supports biomarker research to improve diagnosis of frontotemporal degeneration.
Applications are open to:
- Academic medical centers, universities or non-profits. Industry partnerships are encouraged.
- Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are eligible
The award provides up to 700,000 USD for up to 2 years, including 10% indirect costs.
Applications close May 9, 2025.